Biopharmaceutical research companies are conduct- ing or have conducted more than 8,200 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the more than 8,200 clinical trials, more than 4,300 target the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.
"Freedom fuels innovation, and through our proud tradition of bold thinking and personal freedom, Texas is a natural fit for industries looking to create cutting-edge treatments, develop cures and improve lives. I’m proud of Texas’ ranking in clinical studies, and believe our state has the workforce, talent, universities and business climate to become a national leader for biotech research, development and commercialization." --Governor Rick Perry